InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001415889-24-005975 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2024-02-29 2024-02-27 ELAN Simmons Jeffrey N Pres, CEO AND Dir, Dir F - Tax $16.46 -64.5K 1.23M -5% -$1.06M
2024-02-29 2024-02-27 ELAN Simmons Jeffrey N Pres, CEO AND Dir, Dir A - Grant $0.00 +148.1K 1.29M +13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-27 F D 64,527 $16.46 1,228,742 D — —
2 Common Common Stock 2024-02-27 A A 148,084 $0.00 1,293,269 D — — (F1) Includes 2,000 shares acquired on March 31, 2023, and 616 shares acquired on June 30, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.